NCT01979523 2026-03-19Trametinib With or Without GSK2141795 in Treating Patients With Metastatic Uveal MelanomaNational Cancer Institute (NCI)Phase 2 Active not recruiting42 enrolled 13 charts
NCT05308901 2025-07-25Lenvatinib Plus Pembrolizumab In Patients With Immune Checkpoint Inhibitor Naïve Metastatic Uveal MelanomaProvidence Health & ServicesPhase 2 Active not recruiting6 enrolled 11 charts